CASE REPORT
Accepted on 21 Oct 2025
Case Report of Possible Association between Dermatomyositis and Trastuzumab Deruxtecan Therapy of Triple-Negative Breast Cancer Patient
doi 10.3389/fimmu.2025.1636581
- 108 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Advancements in Targeted Neoadjuvant and Adjuvant Therapies for Drug-Resistant Breast Cancers
Advancements in Targeted Neoadjuvant and Adjuvant Therapies for Drug-Resistant Breast Cancers
661
Total downloads
5,598
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 30 Sep 2025
Evaluation of real-world follow-up methods and their association with adherence and safety in adjuvant breast cancer therapy: a retrospective study
doi 10.3389/fonc.2025.1661727
- 953 views
ORIGINAL RESEARCH
Accepted on 19 Sep 2025
Personalized medicine in Triple-Negative Breast Cancer: Combining Neoantigen Vaccination and Genomic Profiling in a patient Undergoing Neoadjuvant Chemotherapy
doi 10.3389/fonc.2025.1623402
- 635 views
ORIGINAL RESEARCH
Published on 09 Sep 2025
Correlation study of tumor-infiltrating lymphocytes combined with residual cancer burden and prognosis in breast cancer patients receiving neoadjuvant chemotherapy
doi 10.3389/fonc.2025.1538326
- 841 views
REVIEW
Published on 27 Aug 2025
Immunotherapy resistance in triple-negative breast cancer: Molecular mechanisms, tumor microenvironment, and therapeutic implications
doi 10.3389/fonc.2025.1630464
- 1,917 views
- 1 citation
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Breast Cancer
Participating Journals
Frontiers in Endocrinology
- 4.6 impact factor
- 7.4 citescore
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: